Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzinova, Angitia, Arthrosi, Biogen, Johnson & Johnson, Levicept, Merck, Novartis, Nurix , Samsung Bioepis, Sanofi, Schrödinger, Syndax, Third Harmonic, UCB.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Argenx, Bioinvent, Bristol Myers Squibb, Cabaletta, Cellectar, Fate, Immunewalk Therapeutics, Intensity, Johnson & Johnson, Kelun-Biotech, Memo, Novavax, Pacira, TC Biopharm, Vaxart.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Eluminex, Insmed, Jazz.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascendis, Avidity, Everest, In8bio, Merck, Metsera, Newamsterdam, Polypid, Regeneron, Sanofi, Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Otsuka, Sobi, Valneva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Corcept, Duality, Immunic, Maia, Novartis, Regenxbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaptysbio, Ascletis, Atyr, Corvus, Halo, Immix, Innovent, Insilico, J&J, Moleculin, Sionna, Tolremo, Vasa.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amicus, Ascentage, Beyondspring, Cardiff Oncology, Corcept, Experimental Drug Development Centre, Genmab, Ichnos Glenmark, Immuneoncia, Immunitybio, Imunon, Innovent, Jazz, Johnson & Johnson, Kura, Kyowa Kirin, Nasus, OSE, PDS, Perspective, Remegen, Roche, Traws, Vigil Neuroscience.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, In8bio, Kalvista, Kymera, Lyra, Nervgen, Novartis, Opus Genetics, Pharvaris, Regeneron, Replimune, Reviva, Teva, Viatris, Vera, Verastem, Xilio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avadel, Biolinerx, Enterome, Faron, GC Biopharma, Genentech, Merck, Pfizer, Regeneron, Roche, Sanofi, Summit.